Subscribe To
Why iradimed shares are surging today?
iRadimed Corporation IRMD reported Q4 Fy21 sales of $11.87 million, up 39% Y/Y, beating the consensus...
February 4, 2022, 11:37 am
Why iradimed shares are surging today?
iRadimed Corporation IRMD reported Q4 Fy21 sales of $11.87 million, up 39% Y/Y, beating the consensus...
February 4, 2022, 11:37 am
Why meridian bioscience's shares are rising today?
Meridian Bioscience Inc VIVO has posted Q1 Fy22 sales of $88.2 million, down 4.9% Y/Y, sharply beatin...
February 4, 2022, 11:30 am
Why meridian bioscience's shares are rising today?
Meridian Bioscience Inc VIVO has posted Q1 Fy22 sales of $88.2 million, down 4.9% Y/Y, sharply beatin...
February 4, 2022, 11:30 am
Why meridian bioscience's shares are rising today?
Meridian Bioscience Inc VIVO has posted Q1 Fy22 sales of $88.2 million, down 4.9% Y/Y, sharply beatin...
February 4, 2022, 11:30 am
Construction partners q1 earnings exceed expectations; maintains fy22 outlook
Construction Partners Inc ROAD reported first-quarter Fy22 revenue growth of 49.3% year-over-year t...
February 4, 2022, 10:34 am
Construction partners q1 earnings exceed expectations; maintains fy22 outlook
Construction Partners Inc ROAD reported first-quarter Fy22 revenue growth of 49.3% year-over-year t...
February 4, 2022, 10:34 am
Construction partners q1 earnings exceed expectations; maintains fy22 outlook
Construction Partners Inc ROAD reported first-quarter Fy22 revenue growth of 49.3% year-over-year t...
February 4, 2022, 10:34 am
Spectrum brands clocks 2.9% sales growth in q1; notes margin pressure
Spectrum Brands Holdings Inc SPB reported first-quarter Fy22 sales growth of 2.9% year-on-year, to $...
February 4, 2022, 8:50 am
Spectrum brands clocks 2.9% sales growth in q1; notes margin pressure
Spectrum Brands Holdings Inc SPB reported first-quarter Fy22 sales growth of 2.9% year-on-year, to $...
February 4, 2022, 8:50 am
Spectrum brands clocks 2.9% sales growth in q1; notes margin pressure
Spectrum Brands Holdings Inc SPB reported first-quarter Fy22 sales growth of 2.9% year-on-year, to $...
February 4, 2022, 8:50 am
Bristol myers q4 revenue, fy22 sales outlook lag consensus
Bristol Myers Squibb & Co BMY has posted Q4 revenues of $11.98 billion, an increase of 8%, missing the consensus estimate of $12.08 billion. Get ...
February 4, 2022, 8:30 am
Bristol myers q4 revenue, fy22 sales outlook lag consensus
Bristol Myers Squibb & Co BMY has posted Q4 revenues of $11.98 billion, an increase of 8%, missing the consensus estimate of $12.08 billion. Get ...
February 4, 2022, 8:30 am
Bristol myers q4 revenue, fy22 sales outlook lag consensus
Bristol Myers Squibb & Co BMY has posted Q4 revenues of $11.98 billion, an increase of 8%, missing the consensus estimate of $12.08 billion. Get ...
February 4, 2022, 8:30 am
Regeneron's q4 sales, profits more than double with boost from covid-19 treatment sales
Regeneron Pharmaceuticals Inc REGN earned $23.72 per share for Q4 Fy21, more than double from $9.53 ...
February 4, 2022, 8:01 am
Regeneron's q4 sales, profits more than double with boost from covid-19 treatment sales
Regeneron Pharmaceuticals Inc REGN earned $23.72 per share for Q4 Fy21, more than double from $9.53 ...
February 4, 2022, 8:01 am
Regeneron's q4 sales, profits more than double with boost from covid-19 treatment sales
Regeneron Pharmaceuticals Inc REGN earned $23.72 per share for Q4 Fy21, more than double from $9.53 ...
February 4, 2022, 8:01 am
Lannett's q2 sales, profit hit by pricing pressures, lowers fy22 outlook
Lannett Company Inc LCI reported Q2 Fy22 sales of $86.51 million, missing the consensus of $90.21 mil...
February 4, 2022, 7:28 am
Lannett's q2 sales, profit hit by pricing pressures, lowers fy22 outlook
Lannett Company Inc LCI reported Q2 Fy22 sales of $86.51 million, missing the consensus of $90.21 mil...
February 4, 2022, 7:28 am
Lannett's q2 sales, profit hit by pricing pressures, lowers fy22 outlook
Lannett Company Inc LCI reported Q2 Fy22 sales of $86.51 million, missing the consensus of $90.21 mil...
February 4, 2022, 7:28 am